SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Idorsia Seeks US Label Update for Quviviq Daytime Functioning Benefits

Idorsia says it is seeking a US label update for Quviviq. The headline also reports first patient enrollment in DARI-DREAM, but the body is truncated before completing that detail.

Related stories